Innovative Research On Therapies For Neurodegenerative Disease 

 

We employ the latest technology and innovations

What We Do

Cognitive synergy corporation is a research-based biopharmaceutical company focused on the discovery and development of innovative medicines. The company was established in 2017 and have been striving to resolve the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development. 

Who We Are

Cognitive synergy corporation with our effective drug discovery process based on broad capabilities and deep experience in small molecule drug discovery, starting from target validation up to the selection of a clinical candidate, we powerfully execute fully integrated drug discovery programs combining all of Cognitive synergy corporation’s core skills in biology, neuroscience and chemistry. Cognitive synergy corporation is built on robust capabilities and experience in assay development and screening, medicinal and synthetic chemistry, computer-aided drug design, structural biology, in vitro pharmacology, ADME/DMPK and analytical testing. In collaboration with proven and experienced partners and universities, we are well equipped with pharmacological and efficacy testing with in vivo models of disease.

For years, Cognitive Synergy Corporation's research program has achieved advancements that were once thought impossible. As we bring new products into clinical development, our goal remains the same – to discover, develop and commercialize therapeutics that transform care for people around the world.